RxDoctor Payments Data

Mishita Goel

Detroit, MINPI 1457912685

Payments from drug & device makers

What this record shows

This record is dominated by grants: $13,500 of the $20,199 with a category attached, or 66.8%. Abbott accounts for 80.8% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $17,596, more than ten times the $116 reported in 2021.

$20,199in general payments, 2019–2025

Across 104 payments — averaging $194.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$16K
  • Medtronic$829
  • Boston Scientific$634
  • Amgen$375
  • Abiomed$371
  • Penumbra, Inc.$162
  • plus $2K from 19 others

What the payments were for

  • Grants$13,50067%
  • Travel & lodging$1,3587%
  • Food & beverage$4,88624%
  • Education$4552%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →